We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
+4.95%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.17B
AUM Growth
+$11.1M
Cap. Flow
-$121M
Cap. Flow %
-3.83%
Top 10 Hldgs %
22.62%
Holding
353
New
18
Increased
114
Reduced
136
Closed
24

Top Buys

Rank Stock Value
1
NE
Noble Corporation
NE
+$14M
2
WMT icon
Walmart Inc
WMT
+$4.45M
3
OTEX icon
Open Text
OTEX
+$4.03M
4
TJX icon
TJX Companies
TJX
+$3.63M
5
V icon
Visa
V
+$2.89M

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$45.1M
2
APA icon
APA Corp
APA
+$22.8M
3
BUD icon
AB InBev
BUD
+$20.6M
4
AMP icon
Ameriprise Financial
AMP
+$16.1M
5
PRGO icon
Perrigo
PRGO
+$10.4M

Sector Composition

Rank Sector Weight
1 Healthcare 18.17%
2 Industrials 13.79%
3 Technology 13.42%
4 Financials 9.99%
5 Energy 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
26
Ecolab
ECL
$78.6B
$39.7M 1.25%
356,610
-4,037
-1% -$433K
CVX icon
27
Chevron
CVX
$383B
$39.1M 1.23%
299,525
+3,593
+1% +$447K
HD icon
28
Home Depot
HD
$332B
$39M 1.23%
481,446
+3,945
+0.8% +$311K
PAYX icon
29
Paychex
PAYX
$41.4B
$36.9M 1.17%
889,022
-5,295
-0.6% -$218K
V icon
30
Visa
V
$673B
$36.4M 1.15%
690,708
+55,276
+9% +$2.89M
MRK icon
31
Merck
MRK
$321B
$35.6M 1.12%
645,052
-1,449
-0.2% -$79K
PFE icon
32
Pfizer
PFE
$142B
$33.1M 1.04%
1,174,433
+3,643
+0.3% +$104K
TRMB icon
33
Trimble
TRMB
$13.3B
$32.1M 1.01%
870,081
+3,579
+0.4% +$134K
EXPD icon
34
Expeditors International
EXPD
$21.8B
$31.9M 1.01%
722,911
-112,331
-13% -$4.83M
ABBV icon
35
AbbVie
ABBV
$455B
$31.6M 1%
559,054
-2,412
-0.4% -$127K
CVS icon
36
CVS Health
CVS
$134B
$31.5M 0.99%
417,764
+5,027
+1% +$380K
STT icon
37
State Street
STT
$50.2B
$31.4M 0.99%
466,781
-9,679
-2% -$637K
EMR icon
38
Emerson Electric
EMR
$83.3B
$29.4M 0.93%
443,006
+2,198
+0.5% +$148K
JPM icon
39
JPMorgan Chase
JPM
$933B
$28.9M 0.91%
500,856
+5,220
+1% +$293K
GILD icon
40
Gilead Sciences
GILD
$163B
$27.6M 0.87%
332,486
+26,059
+9% +$2.03M
INTC icon
41
Intel
INTC
$460B
$27.1M 0.86%
878,292
-531
-0.1% -$14.6K
GSK icon
42
GSK
GSK
$104B
$26.7M 0.84%
400,069
EMLP icon
43
First Trust North American Energy Infrastructure Fund
EMLP
$4.09B
$26.4M 0.83%
977,780
+22,665
+2% +$578K
TD icon
44
Toronto Dominion Bank
TD
$198B
$26.1M 0.82%
507,616
+18,401
+4% +$893K
LLTC
45
DELISTED
Linear Technology Corp
LLTC
$25.7M 0.81%
547,028
+26,485
+5% +$1.23M
ABT icon
46
Abbott
ABT
$183B
$24.7M 0.78%
602,822
+1,318
+0.2% +$51.8K
SU icon
47
Suncor Energy
SU
$78.8B
$23.4M 0.74%
550,078
-2,742
-0.5% -$107K
MET icon
48
MetLife
MET
$62.5B
$23.1M 0.73%
467,270
+8,382
+2% +$392K
LQD icon
49
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$22.7M 0.72%
190,738
-815
-0.4% -$96.4K
ADP icon
50
Automatic Data Processing
ADP
$105B
$22.7M 0.72%
325,473
-1,388
-0.4% -$94.7K

Similar funds

Welch & Forbes's Q2 2014 Portfolio in Review

As of Q2 2014, Welch & Forbes held 353 positions worth $3.17B, up 0.35% from $3.16B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Welch & Forbes withdrew a net $121M in Q2 2014, closing 24 positions and reducing 136 holdings. Its most notable exit was Ansys, an estimated $45.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Welch & Forbes opened a new position in Noble Corporation worth $14.9M.

  • Welch & Forbes's largest Q2 2014 buy was Noble Corporation: 509,476 shares worth $14.9M.
  • Welch & Forbes added most to Walmart Inc in Q2 2014, an estimated $4.45M increase.
  • Welch & Forbes's biggest Q2 2014 reduction was Expeditors International, cutting an estimated $4.83M.
  • Welch & Forbes fully exited Ansys in Q2 2014, selling an estimated $45.1M.
  • Welch & Forbes's ten largest holdings make up 23% of its $3.17B portfolio in Q2 2014.
  • Welch & Forbes opened 18 new positions and closed 24 in Q2 2014.
  • Welch & Forbes's portfolio value rose 0.35% quarter-over-quarter to $3.17B.

Based on Welch & Forbes's 13F filing for Q2 2014, filed 31 Jul 2014.